Natural Treatment Options for Alopecia... ...
Scientists uncover genetic cause of rare autoimmun...
Study reveals molecular mechanism of genetic varia...
Feet first: AI reveals how infants connect with th...
Study reveals molecular mechanism of genetic varia...
Scientists uncover genetic cause of rare autoimmun...
The Current State and Future Prospects of Synthetic Biology...
August 26,2024 0
Pelage Pharmaceuticals Advances Hair Loss Treatment with Pha...
August 14,2024 0
Fighting obesity: The GLP-1 revolution...
September 24,2024 0
Scientists uncover genetic cause of rare autoimmune disorder...
October 09,2024 0
Advancements in Digital Pathology: The Role of AI and Large ...
August 19,2024 0
Artificial pancreas shows promise in people with type 1 diab...
September 13,2024 0
Category
Oncology
Gastroenterology
Pediatrics
Ophthalmology
Medicine
Medical research
Q and A
Healthy Lifestyle
Neurology
Anesthesiology & Pain
Most Read
Celebrating Innovation in Life Sciences: The 2024 Prix Galien USA Awards

Celebrating Innovation in Life Sciences: The 2024 Prix Galien USA Awards

The Prix Galien is often regarded as the equivalent of the Nobel Prize in biopharmaceutical research, highlighting its significance in the scientific community.
Medical research August 13,2024 0
Celebrating Innovation in Life Sciences: The 2024 Prix Galien USA Awards

Celebrating Innovation in Life Sciences: The 2024 Prix Galien USA Awards

The Prix Galien is often regarded as the equivalent of the Nobel Prize in biopharmaceutical research, highlighting its significance in the scientific community.
Medical research August 13,2024 0
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Why MDMA did NOT get FDA approval...
More News
Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainIn the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T
Oncology November 09,2024 0
Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainIn the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T
Oncology November 09,2024 0
Scientists glue two proteins together, driving cancer cells to self-destruct

Scientists glue two proteins together, driving cancer cells to self-destruct

by Rachel Tompa,Stanford University Medical CenterTurning kinase inhibitors into activators of therapeutic genes. Credit:Science(2024). DOI: 10.1126/science.adl5361Our bodies divest
Oncology November 09,2024 0
Scientists glue two proteins together, driving cancer cells to self-destruct

Scientists glue two proteins together, driving cancer cells to self-destruct

by Rachel Tompa,Stanford University Medical CenterTurning kinase inhibitors into activators of therapeutic genes. Credit:Science(2024). DOI: 10.1126/science.adl5361Our bodies divest
Oncology November 09,2024 0
New CAR-T cells offer on-demand control for cancer treatment

New CAR-T cells offer on-demand control for cancer treatment

byLudwig Cancer ResearchCredit: Pixabay/CC0 Public DomainLudwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that c
Oncology November 09,2024 0
New CAR-T cells offer on-demand control for cancer treatment

New CAR-T cells offer on-demand control for cancer treatment

byLudwig Cancer ResearchCredit: Pixabay/CC0 Public DomainLudwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that c
Oncology November 09,2024 0
Researchers unveil inhibition mechanism of receptors on natural killer cells

Researchers unveil inhibition mechanism of receptors on natural killer cells

byUniversity of Science and Technology of ChinaSchematics of GPR34 regulating ILC1 function during tumor progression and suppression. Credit: Prof. Zhou's teamA research team led by Prof. Zh
Oncology November 09,2024 0
Researchers unveil inhibition mechanism of receptors on natural killer cells

Researchers unveil inhibition mechanism of receptors on natural killer cells

byUniversity of Science and Technology of ChinaSchematics of GPR34 regulating ILC1 function during tumor progression and suppression. Credit: Prof. Zhou's teamA research team led by Prof. Zh
Oncology November 09,2024 0
Pembrolizumab aids survival with high-risk endometrial cancer

Pembrolizumab aids survival with high-risk endometrial cancer

by Lori SolomonPembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published onl
Oncology November 09,2024 0
Pembrolizumab aids survival with high-risk endometrial cancer

Pembrolizumab aids survival with high-risk endometrial cancer

by Lori SolomonPembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published onl
Oncology November 09,2024 0
Immune cell discovery offers new potential for cancer immunotherapy

Immune cell discovery offers new potential for cancer immunotherapy

byEmory UniversityProposed models of T cell differentiation states in TDLNs. Credit:Nature(2024). DOI: 10.1038/s41586-024-08076-7Researchers at Winship Cancer Institute of Emory Univ
Oncology November 09,2024 0
Immune cell discovery offers new potential for cancer immunotherapy

Immune cell discovery offers new potential for cancer immunotherapy

byEmory UniversityProposed models of T cell differentiation states in TDLNs. Credit:Nature(2024). DOI: 10.1038/s41586-024-08076-7Researchers at Winship Cancer Institute of Emory Univ
Oncology November 09,2024 0
Researchers discover key genetic mutations in bowel cancer cells that lead to resistance to WRN inhibitors

Researchers discover key genetic mutations in bowel cancer cells that lead to resistance to WRN inhibitors

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers have discovered key mutations in certain cancer cells that make them resistant to WRN inhibit
Oncology November 09,2024 0
Researchers discover key genetic mutations in bowel cancer cells that lead to resistance to WRN inhibitors

Researchers discover key genetic mutations in bowel cancer cells that lead to resistance to WRN inhibitors

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers have discovered key mutations in certain cancer cells that make them resistant to WRN inhibit
Oncology November 09,2024 0
Unlocking the potential of bispecific antibody-drug conjugates for targeted cancer therapy

Unlocking the potential of bispecific antibody-drug conjugates for targeted cancer therapy

by Frontiers JournalsCredit: Unsplash/CC0 Public DomainAntibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines
Oncology November 09,2024 0
Unlocking the potential of bispecific antibody-drug conjugates for targeted cancer therapy

Unlocking the potential of bispecific antibody-drug conjugates for targeted cancer therapy

by Frontiers JournalsCredit: Unsplash/CC0 Public DomainAntibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines
Oncology November 09,2024 0
Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

by Tsinghua University PressThis schematic illustrates the process of developing patient-derived skin tumor organoids from Dermatofibrosarcoma Protuberans (DFSP). The workflow includes organoid cultur
Oncology November 09,2024 0
Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

by Tsinghua University PressThis schematic illustrates the process of developing patient-derived skin tumor organoids from Dermatofibrosarcoma Protuberans (DFSP). The workflow includes organoid cultur
Oncology November 09,2024 0
Cancer detection recovered following pandemic disruptions

Cancer detection recovered following pandemic disruptions

by Lori SolomonOverall, cancer detection in the United States recovered meaningfully in 2021 following substantial disruptions in 2020, according to a studypublishedonline Oct. 14 in
Oncology November 09,2024 0
Cancer detection recovered following pandemic disruptions

Cancer detection recovered following pandemic disruptions

by Lori SolomonOverall, cancer detection in the United States recovered meaningfully in 2021 following substantial disruptions in 2020, according to a studypublishedonline Oct. 14 in
Oncology November 09,2024 0
More News
Week’s Top
Podcasts
... Announcement of the 2024 Nobel Prize in Physiology or Medicine Nobel Prize in Physiology or Medicine... ... Announcement of the 2024 Nobel Prize in Chemistry The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2024 with one half to David Baker, University of Was... ... AlphaFold: The making of a scientific breakthrough The inside story of the DeepMind team of scientists and engineers who created AlphaFold, an AI system that is recognised as a solution to "p...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
APP
Medicine.net
Meditionary
PanWriting
PanDraw